Graphite explorer GreenRoc celebrates year of ‘enormous progress’

GreenRoc has released results for the year to 30th November 2022 in which the company confirmed the maiden resource estimate for the Amitsoq Project and pursued further evaluation of the project.

In March 2022, the maiden resource estimate of 8.28Mt at 19.75% graphitic carbon was declared for the Amitsoq Project.

In addition, the company has undertaken a 19 hole drill programme totalling of 2,844m – the company said every hole intersected significant graphite layers.

The drill programme culminated in the trebling of the resource to 23.05 Mt at a grade of 20.41% graphitic carbon.

Despite the year of ‘enormous progress’, GreenRoc shares are down 50% over the past year.

“Enormous progress has been made, in particular, at Amitsoq, where we have built up a substantial graphite resource and have done so without any sacrifice to grade, with Amitsoq now firmly established among a very select grouping worldwide of graphite deposits with resource grades averaging more than 20%,” said GreenRoc’s Chairman, George Frangeskides.

“At the same time, we have greatly advanced our metallurgical test work programme in order to demonstrate the amenability of our graphite to the production of high purity spherical graphite which is in such demand for electric vehicles.”

“These achievements mean that we can now focus our efforts for the rest of this year on our ongoing development work and furthering our discussions with potential strategic partners, putting us in a very strong position as we seek to accelerate Amitsoq along the path to production.”

FTSE 100 battered by US rate hike, BoE also hikes

The FTSE 100 has felt the pressure of tightening monetary policy in the last 24 hours after the Federal Reserve hiked rates last night and the Bank of England followed suit today.

US stocks were down heavily overnight and the selling spilled over into the European session.

The Federal Reserve hiked rates by 25bps to 4.75% while the Bank of England hiked 25bps to 4.25%.

The Bank of England had little choice but to hike rate after UK inflation accelerated to 10.4% as in February the costs of salads helped push up benchmark CPI.

“The UK is in an economic danger zone,” said Charles White Thomson, CEO at Saxo UK.

Despite the weakness at the beginning of the session, the FTSE 100 edged off the lows as the session progressed. The BoE decision to hike 25bps saw the FTSE 100 back above 7,500.

There is consensus building major central banks are nearing the end of their hiking cycles and this helped the FTSE 100 of the worst levels of the session.

“We understand why there is a growing chorus of commentators calling for a pause here,” said Jonathan Moyes, Head of Investment Research, Wealth Club.

“The US and Europe have come very close to a banking crisis over the previous two weeks and monetary conditions will tighten significantly as a result, placing further strain on the sector.”

HSBC and Standard Chartered were among the top fallers as a stronger GBP/USD hit dollar earners.

NatWest was up 1.4% while Endeavour Mining was the best performer. Gold has been edging towards $2,000 since the start of the SVB saga.

Federal Reserve disappointment?

The selling of equities began last night after the Federal Reserve hiked rates by 25bps despite concerns recent banking failures at SVB and Credit Suisse were a result of higher interest rates.

Although economist consensus expectations were for a 25bps, some thought the Fed may take a break from rate hikes after disruption in the financial system tightened conditions. Not so.

The Fed choose to continue the fight against inflation with higher rates.

“My colleagues and I are acutely aware that high inflation imposes significant hardship as it erodes purchasing power, especially for those least able to meet the higher cost of essentials like food, housing, and transportation,” said Fed chairman Jerome Powell in a press conference following the rate decision

Many now expect the US will enter a recession this year and a pivot looks a long way off.

AIM movers: Zinnwald Lithium premium subscription and ex-dividends

0

Zinnwald Lithium (LON: ZNWD) is the highest riser today after its successful share issue at a premium to the previous market price. A total of £18.75m was raised at 10.41p a share and the price has risen by 24.4% to 10.25p. German critical metals company Advanced Metallurgical Group (Euronext: AMG) subscribed for a 25.1% stake, while a Primary Bid offer enabled other investors to participate at the same price. The cash will fund the definitive feasibility study of the Zinnwald lithium project in Saxony, which can supply battery markets. It is currently estimated to have a NPV8 of $1.6bn and a payback period of 3.3 years. The output could reach 17,000t/year LiOH. AMG has Europe’s first lithium hydroxide refinery at Bitterfield-Wolfen. Tamesis Partners has a target share price of 40p.

Full year results from product life cycle software Sopheon (LON: SPE) were in line with the January trading statement with new companies signing up for a SaaS contracts. Recurring revenues were 61% of the total. The share price is 14.8% higher at 660p.

Eco Animal Health (LON: EAH) had a strong fourth quarter and demand for pig treatment Aivlosin was lightly higher than expected in China. This means that full year results will be marginally better than expected. A pre-tax profit of £3.81m was forecast. The share price rose 11.7% to 109.5p.

SRT Marine Systems (LON: SRT) has won a £145m project to provide marine detection systems to a foreign coast guard customer. The UK government is providing a loan to finance the contract and once that is agreed the contract will start. The validated sales pipeline is worth £535m. However, this year’s systems revenues will be lower than expected with projects delayed until the next financial year.  Forecast revenues for the year to March 2023 have been slashed from £56.6m to £30m and there will be a loss. Even so, the share price improved by 11.8% to 42.5p.

Cyber security company Osirium Technologies (LON: OSI) reported a slightly higher loss of £3.59m in 2022 and cash levels are declining. Since then, £1mm of annualised savings have been secured. The switch of focus to partners should accelerate customer acquisition. The share price slumped 17.3% to 2.15p, which is just above the all-time low.

Safestyle UK (LON: SFE) reported 2022 results showing a £4.4m underlying loss. The replacement windows company could return to profit this year, but there are still underlying economic concerns, high interest rates and pressure on consumer spending. This year’s pre-tax profit forecast has been cut from £3.6m to £2m. The share price has fallen 15.3% to 24.55p.

An independent report has been commission to look into related party issues at Inland Homes (LON: INL). The shares will be suspended on 3 April until the accounts are published. A £5m fundraising at 10p a share is being considered. Matthew Robinson and Trevor Sawyer have been appointed as non-execs. The shares are down by 13.8% to 6.25p.

Ex-dividends

Craneware (LON: CRW) is paying a dividend of 12.5p a share and the share price is 40p lower at 1260p.

Finsbury Food (LON: FIF) is paying an interim dividend of 0.87p a share and the share price is unchanged at 94p.

Fonix Mobile (LON: FNX) is paying an interim dividend of 2.36p a share and the share price is down 4p to 198.5p.

Hargreaves Services (LON: HSP) is paying an interim dividend of 3p a share and the share price fell 2p to 399.5p.

i3 Energy (LON: I3E) is paying a dividend of 0.17p a share and the share price is 0.18p lower at 17.1p.

MTI Wireless Edge (LON: MWE) is paying a final dividend of 3 cents a share and the share price fell 3p to 51p.

Nichols (LON: NICL) is paying a final dividend of 15.3p a share and the share price is down by 12.5p to 1047.5p.

FW Thorpe (LON: TFW) is paying an interim dividend of 1.62p a share and the share price reduced by 8p to 354p.

Viritech bolsters board and accelerates hydrogen powertrain partnerships

Sponsored by Viritech

Viritech, the leading developer of high-performance hydrogen powertrain solutions for the automotive, aerospace, marine, and distributed power industries, has announced that Phil Wild will join as Associate Director board member from 1st April to help develop its commercial scale-up plan for 2024 onwards.

Viritech is a cleantech technology company which develops advanced hydrogen powertrain technology for licensing to vehicle manufacturers and major component suppliers.

Find out more on Viritech’s Crowdfunding page

Following two years of R&D, Viritech is focussed on a development pipeline of 24 products for hydrogen powertrains, including hydrogen storage, advanced battery systems and power electronics. It will introduce these over the next 24-months, with sales revenues expected to commence by Q4 this year.

In addition to its ambitious product development pipeline, Viritech has also recently announced two major partnerships. The first is with the Anand Group in India to establish a manufacturing JV in 2024. The second is with Horiba MIRA, a leading European automotive engineering and testing consultancy, and Intelligent Energy, the leading British fuel cell manufacturer, to develop hydrogen fuel cell powertrain solutions suitable for 40-tonne Heavy Goods Vehicles (HGVs). Further high-profile projects in partnership with major manufacturers are expected to be announced in the near future.

With the company demonstrating commercial engagement with major global manufactures over the next six months, Mr Wild will work with Viritech’s CEO & Founder, Timothy Lyons to develop the company’s long-term scale-up strategy for implementation in 2024.

To support this plan, the company will be seeking a £5m equity raise later this year, targeting Venture Capital investors, Strategic Investors and Family Offices.

Find out more on Viritech’s Crowdfunding page

Osirium Technologies bookings and revenue jumps

Osirium Technologies, the UK-based cybersecurity software company, said a 46% jump in their customer base and 96% renewal rate were evidence of a significant year of progress in 2022.

Total revenue rose 31% to £1.92m in 2022, up from £1.47m in 2021. Total bookings rose 86% to £3m.

Osirium said their Privileged Process Automation (PPA) and Privileged Endpoint Management (PEM) offerings were now contributing materially to bookings and will add to sales from the more established Privileged Access Management.

Osirium’s systems allow organisations to automate and enhance their cyber security programmes.

The company said the higher customer base provided the platform for upselling opportunities in the future.

“It has been another year of significant progress for Osirium in which we have achieved record levels in bookings and revenue and further grown our customer base while also taking substantial steps to reach cash breakeven and beyond,” said Stuart McGregor, CEO of Osirium

“We have started the new year with a refocused sales strategy and a partner first sales approach, through which we expect to see increased interest across a wider range of sectors and geographies. As privileged security continues to rise up the agenda of IT professionals globally, we are excited for the future and the continued growth of the business.”

AIM movers: Pathfinder Minerals finalises disposal and Anpario profit slump

2

Pathfinder Minerals (LON: PFP) has signed a conditional sale and purchase agreement with Acumen Advisory for the disposal of IM Minerals. This was originally announced earlier this year and the deal includes claims against the Mozambique government. The deal requires shareholder approval. There is an initial £2m payment and a contingent payment of the higher of $24m or 20% of net recoveries from the claim. The share price jumped 16.7% to 0.525p.

Fevertree Drinks (LON: FEVR) reported a 11% rise in full year revenues to £344m. Underlying EBITDA was £39.7m and the guidance for this year is between £36m and £42m. US and European revenues increased, but UK revenues were lower even after raising selling prices. Even so, the share price has recovered 9.83% to 1184p – the highest level this year.

Evgen Pharma (LON: EVG) has announced headline results from the phase Ib pharmacokinetic study with the enteric-coated tablet of SFX-01. This shows delivery of the active ingredient to the intestine, so there should be fewer gastrointestinal side effects. The share price is 7.79% higher at 4.15p.

NAHL Group (LON: NAH) is still in the process of reaping the benefit of its change in strategy, but it appears set for strong cash generation over the next three years as more personal injury business goes through its own law firm. The 2022 pre-tax profit of £600,000 was after profit shared with joint ventures. Net debt is £13.3m and could fall to £10.3m by the end of 2023 and to £6.3m one year later. The share price improved 6.23% to 37.5p. That is the highest it has been since last summer.

Full year results from Anpario (LON: ANP) were in line with forecasts with pre-tax profit falling by more than one-third to £3.7m. Net cash was £13.6m. Raw materials prices are reducing, which should help this year. Peel Hunt has reduced its 2023 earnings forecast by 35% to 11.2p. That will still cover an unchanged total dividend of 10.2p a share. The share price dived 29% to 220p.

Cloud video editing technology developer Blackbird (LON: BIRD) increased annual revenues by 38% to £2.85m. The loss increased to £2.2m. There was still £10m in the bank at the end of 2022. There are £3.43m of contracted revenues with £1.6m to be recognised this year. The share price slumped 24.2% to 8.15p.  

Capital equipment supplier Mpac Group (LON: MPAC) reported a fall in pre-tax profit from £8.6m to £3.5m, but this was expected. There are signs that trading is recovering and the order book of £67.2m covers nearly two-thirds of forecast revenues for 2023. Pre-tax profit could recover to £7m this year. Adam Holland will succeed Tony Steels as chief executive. The share price fell 10.7% to 250p.

Shares in oil and gas explorer Longboat Energy (LON: LBE) fell a further 5.56% to 8.5p following yesterday’s 2022 results, which included a write down on four wells. The total loss was £15.5m. The next exploration well is not due until the third quarter. Longboat Energy is seeking acquisitions.

FTSE 100 in wait and see mode ahead of US interest rate decision

The FTSE 100 was marginally lower on Wednesday as markets braced for the Federal Reserve’s interest rates decision later today.

Contagion from SVB and Credit Suisse appears to be contained which has helped sentiment improve this week.

In addition, bargain hunters are seeing value in FTSE 100 stocks after recent volatility, and their buying pressure will likely continue to provide support for the index.

UK banks were the standout performers as fears about the global banking system abated.

Barclays was up over 3% and NatWest gained more than 2%.

UK CPI

UK CPI unexpectedly rose in February, after months of declines, and raised the prospect of another Bank of England rate hike in the near future.

Higher interest rates will mount pressure on many areas of the economy but will help banking profitability.

Federal Reserve

The Federal Reserve are faced with a difficult decision later today; continue the fight against high level of inflation with a 50 bps rate hike, or accommodate market fears with a 25bps hike, or even no hike at all.

The Federal Reserve is trying carefully engineer a soft landing in the US economy by tightening monetary policy but not causing a recession. Looking to history for a playbook of tightening cycles, this is very difficult to achieve and many expect a recession.

No matter the decision later this evening, one would expect swings in US stocks over night that could spill over into tomorrow’s European session.

MicroSalt issues operational update ahead of proposed IPO

Ahead of their proposed IPO this year, Tekcapital portfolio company MicroSalt has issued an operational update and insight into their commerical progress.

Before potentially listing in London this year, MicroSalt have unveiled commercial achievements and summarised their strategic partnerships.

Highlights include the promising signs from the online sales activity in MicroSalt shakers and the ongoing relationship with Kroger.

SaltMe Crisps are stocked in thousands of Kroger stores across the US making the low-sodium products available to millions of health conscious consumers.

Also of note is progress in tests with major food companies. This could lead to significant future revenues.

Earlier this year, MicroSalt launched a media campaign with the National Pancreas Foundation which includes access to approximately 100,000 medical professionals and 170 hospitals.

MicroSalt, a Tekcapital portfolio company, appointed Zeus Capital as their Nomad ahead of a proposed IPO this year.

NatWest shares: recent volatility unearths opportunity in the UK bank

Despite the recent volatility being largely isolated to US and Swiss banks, the rout in banking stocks was far reaching and UK banks, including NatWest, suffered.

With NatWest shares having given up all of this years gains after a questionable outlook for 2023 in their full year results and external pressures from global banking sector volatility, the company is now at a level that may provide an entry point for investors looking to add the bank to their portfolio.

US & UK Bank valuations

Notwithstanding the sharp drop in banking shares, the valuation of the world’s largest financial institutions have been under the microscope in recent weeks.

The valuation trends of UK banks differ significantly to US banks and much was made of the low price-to-book ratio of some of the US regional banks in the midst of the recent volatility. 

In fact, after the US regional banks had lost around 80-90% of their value, their price-to-book valuation was the same as UK banks’ long term average.

For example, First Republic Bank trades around 0.2x book value, even after losing much of its value. Barclays trades at 0.3x book value and hasn’t traded a premium to book value for years.

NatWest, like most FTSE 100 banks, trades at a discount to their book value. This has become normal since the financial crisis but also suggests poor sentiment attached to UK banks. NatWest trades at 0.7x book value; the same as Lloyds, but slightly higher than Barclays.

Nonetheless, compared to their peers, NatWest will be starting to catch the eye of investors seeking a yield and opportunity for capital appreciation.

NatWest Dividend Yield

After years offering a dismal yield, NatWest has slowly become a company that provides a respectable yield to investors. With a 5.4% historical yield, NatWest has the attributes many income investors would look for. A dividend cover of 2.9 means ample space for increased payouts in the future.

With Natwest currently trading around 6.4x historical earnings, the shares don’t appear to look attractive compared to peers. However, Natwest was not as heavily hit during the recent bout of volatility which suggests the market feels the company deserves a premium valuation to peers.

2023 Outlook

Although total income grew 28.3% to £2,877 million in 2022, the outlook for 2023 was punctuated by a predicted peak in net interest margins.

This will curb enthusiasm for banking shares as it will cap earnings potential.

In addition, the fluid state of the UK economy should be a consideration for NatWest shares, despite forecasts from the OBR and Bank of England improving of late.

Natwest’s earnings growth isn’t the main event, rather relative value global banking averages.

AIM Movers: Manx Financial dividend hike and Eqtec falls below placing price

4

Manx Financial (LON: MFX) increased its full year dividend from 24.43p a share to 37.64p a share. Pre-tax profit jumped from £2.2m to £5.2m. Management expects first half lending to be ahead of the same time last year, while provisions should not be higher than the norm. The share price jumped 22.2% to 27.5p.

Promotional retail company SpaceandPeople (LON: SAL) achieved 2022 revenues of £5.5m and momentum has continued into 2023 despite UK rail strikes. The full year results will be announced in early May. The share price rose 12.8% to 75p.

Production has commenced at the ASH-8 onshore Egypt well, where United Oil and Gas (LON: UOG) has a 22% working interest, at a net initial stabilised rate of 656 barrels of oil/day and 0.58 mmscf/day. The share price is 13% higher at 1.3p.

Alliance Pharma (LON: APH) reported a 28% decline in underlying pre-tax profit to £30.3m, but new marketing initiatives and a recovery in China augur well for 2023. There will be higher marketing costs this year and pre-tax profit is expected to bounce back to £37.1m. The focus will be on the current portfolio of consumer and prescription products. Cash generation should help net debt reduce to around £90m. The share price is 1.3% ahead at 58.35p, although it was above 62p earlier in the day.

Waste-to-energy technology developer and operator Eqtec (LON: EQT) is raising £3.5m at 0.22p, with potential for a further £550,000 to be added to the total. The share price dived by 28.1% to 0.205p. The cash will be used on market development centres (MDC), which are used to demonstrate the company’s technology. The first MDC should open in Croatia later this year. This is part of the process to move to a licensing model. There will also be some spending on developing sustainable aviation fuel.

Renalytix (LON: RENX) says the FDA will not complete the process for the marketing authorisation application for kidney disease diagnostic test KidneyIntelX until the second quarter of 2023.The FDA will prepare a reclassification order pending approval. This delay has hit the share price, which is down 13.9% to 77.5p.

Virtual reality technology developer Engage XR (LON: EXR) is dropping its Euronext Growth quotation on 19 April. The share price continues its recent decline with a further 12% drop to 3.4p, which is a new low.

Pressure Technologies (LON: PRES) says Grant Thornton requires additional time to complete the audit of the 2021-22 results, so trading in the shares will be suspended on 3 April. The share price fell 7.23% to 38.5p. Previous accounting policies accounting for defence contracts are deemed not to be compliant with accounting standards. This means that costs will be taken earlier meaning higher profit in future years. The accounting changes will make it easier to return to profit this year. The new finance director will join in May and new banking facilities are being negotiated. The AGM will still be held on 31 March. Richard Staveley, who works with 20% shareholder Harwood Capital, will join the board when after the results are published.